Clinical Trial Update: Nicotine Replacement Therapy for Smoking Cessation in Schizophrenia [Phase 4]

View source ↗

Summary

Phase 4 trial assessing nicotine replacement therapy for smoking cessation in people with schizophrenia or schizoaffective disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Nicotine replacement therapy (nicotine replacement therapy)

Snippet

Sponsor: North Suffolk Mental Health Association | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 4 | Status: COMPLETED